Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Genetic Factors in the Screening and Imaging for Breast Cancer

  • Jongmyung Kim (Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School and Rutgers New Jersey Medical School, Rutgers University) ;
  • Bruce George Haffty (Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School and Rutgers New Jersey Medical School, Rutgers University)
  • Received : 2023.01.03
  • Accepted : 2023.03.01
  • Published : 2023.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

Acknowledgement

Supported in part by the Breast Cancer Research Foundation.

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-249 https://doi.org/10.3322/caac.21660
  2. Kim LS, Lannin DR. Breast cancer screening: is there room for de-escalation? Curr Breast Cancer Rep 2022;14:153-161 https://doi.org/10.1007/s12609-022-00465-z
  3. Lee CS, Monticciolo DL, Moy L. Screening guidelines update for average-risk and high-risk women. AJR Am J Roentgenol 2020;214:316-323 https://doi.org/10.2214/AJR.19.22205
  4. Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, et al. Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. J Am Coll Radiol 2017;14:1137-1143 https://doi.org/10.1016/j.jacr.2017.06.001
  5. Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: a systematic review. Breast 2022;64:85-99 https://doi.org/10.1016/j.breast.2022.04.003
  6. Solikhah S, Nurdjannah S. Assessment of the risk of developing breast cancer using the Gail model in Asian females: a systematic review. Heliyon 2020;6:e03794
  7. Rooney MM, Miller KN, Plichta JK. Genetics of breast cancer: risk models, who to test, and management options. Surg Clin North Am 2023;103:35-47 https://doi.org/10.1016/j.suc.2022.08.016
  8. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886 https://doi.org/10.1093/jnci/81.24.1879
  9. Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006;98:1215-1226 https://doi.org/10.1093/jnci/djj332
  10. Kim DY, Park HL. Breast cancer risk prediction in Korean women: review and perspectives on personalized breast cancer screening. J Breast Cancer 2020;23:331-342 https://doi.org/10.4048/jbc.2020.23.e40
  11. Stevanato KP, Pedroso RB, Dell Agnolo CM, Santos LD, Pelloso FC, Carvalho MDB, et al. Use and applicability of the Gail model to calculate breast cancer risk: a scoping review. Asian Pac J Cancer Prev 2022;23:1117-1123 https://doi.org/10.31557/APJCP.2022.23.4.1117
  12. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004;23:1111-1130 https://doi.org/10.1002/sim.1668
  13. Min JW, Chang MC, Lee HK, Hur MH, Noh DY, Yoon JH, et al. Validation of risk assessment models for predicting the incidence of breast cancer in Korean women. J Breast Cancer 2014;17:226-235 https://doi.org/10.4048/jbc.2014.17.3.226
  14. Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, et al. 10-year performance of four models of breast cancer risk: a validation study. Lancet Oncol 2019;20:504-517 https://doi.org/10.1016/S1470-2045(18)30902-1
  15. Gayther SA, Ponder BA. Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing. Mol Med Today 1997;3:168-174
  16. Kleibl Z, Kristensen VN. Women at high risk of breast cancer: molecular characteristics, clinical presentation and management. Breast 2016;28:136-144 https://doi.org/10.1016/j.breast.2016.05.006
  17. Romualdo Cardoso S, Gillespie A, Haider S, Fletcher O. Functional annotation of breast cancer risk loci: current progress and future directions. Br J Cancer 2022;126:981-993 https://doi.org/10.1038/s41416-021-01612-6
  18. Yanes T, Young MA, Meiser B, James PA. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field. Breast Cancer Res 2020;22:21
  19. Eklund M, Broglio K, Yau C, Connor JT, Stover Fiscalini A, Esserman LJ. The WISDOM personalized breast cancer screening trial: simulation study to assess potential bias and analytic approaches. JNCI Cancer Spectr 2018;2:pky067
  20. Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Giorgi Rossi P, et al. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "my personal breast screening" (MyPeBS) randomised clinical trial. BMC Cancer 2022;22:507
  21. Mitchell G, Antoniou AC, Warren R, Peock S, Brown J, Davies R, et al. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 2006;66:1866-1872 https://doi.org/10.1158/0008-5472.CAN-05-3368
  22. Dumas I, Diorio C. Estrogen pathway polymorphisms and mammographic density. Anticancer Res 2011;31:4369-4386
  23. Lee E, Luo J, Schumacher FR, Van Den Berg D, Wu AH, Stram DO, et al. Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California teachers study. BMC Cancer 2018;18:1072
  24. Sieh W, Rothstein JH, Klein RJ, Alexeeff SE, Sakoda LC, Jorgenson E, et al. Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk. Nat Commun 2020;11:5116
  25. Smolarz B, Polac' I, Romanowicz H. Mammographic breast density and IGF-1 gene polymorphisms rs1520220, rs2946834 and rs6219 in Polish women. Contemp Oncol (Pozn) 2021;25:191-197 https://doi.org/10.5114/wo.2021.109727
  26. Dixon P, Keeney E, Taylor JC, Wordsworth S, Martin RM. Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review. Genet Med 2022;24:1604-1617 https://doi.org/10.1016/j.gim.2022.04.020
  27. Lehman CD, Mercaldo S, Lamb LR, King TA, Ellisen LW, Specht M, et al. Deep learning vs traditional breast cancer risk models to support risk-based mammography screening. J Natl Cancer Inst 2022;114:1355-1363 https://doi.org/10.1093/jnci/djac142
  28. Brentnall AR, Harkness EF, Astley SM, Donnelly LS, Stavrinos P, Sampson S, et al. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res 2015;17:147
  29. Bhowmik A, Eskreis-Winkler S. Deep learning in breast imaging. BJR Open 2022;4:20210060
  30. Yala A, Mikhael PG, Strand F, Lin G, Smith K, Wan YL, et al. Toward robust mammography-based models for breast cancer risk. Sci Transl Med 2021;13:eaba4373